Annual Report 2006 - Boehringer Ingelheim

Product name Active ingredient Indication
aptivus® tipranavir Available as capsules for adults –
used co-administered with 200 mg of ritonavir,
is indicated for combination antiretroviral treatment
of HIV-1-infected adult patients with
evidence of viral replication, who are highly
treatment-experienced or have HIV-1 strains
resistant to multiple protease inhibitors.
atrovent® ipratropium bromide Bronchodilator for maintenance treatment
of bronchospasm associated with chronic
obstructive pulmonary disease, including
chronic bronchitis, emphysema and asthma.
berotec®
dosberotec®
fenoterol a) Symptomatic treatment of acute asthma attacks
b) Prophylaxis of exercise induced asthma
c) Symptomatic treatment of bronchial asthma
and other conditions with reversible airway
narrowing e.g. chronic obstructive bronchitis.
Concomitant anti-inflammatory therapy should be
considered for patients with bronchial asthma and
steroid responsive chronic obstructive pulmonary
disease (COPD).
bisolvon® bromhexine Mucolytic for the treatment of acute and chronic
bronchopulmonary diseases associated with
impaired formation and transport of mucus.
Glossary 143